Two-drug immunotherapy deemed safe for lung cancer patients, study shows
Small cell lung cancer (SCLC) represents approximately 14 percent of all types of lung cancer. Many patients with SCLC respond to initial chemotherapy; however, they eventually relapse and develop progressive disease that ...
Jun 2, 2016
0
76
